Your browser doesn't support javascript.
loading
Methods and clinical biomarker discovery for targeted proteomics using Olink technology.
Wang, Han; Zhao, Tian; Zeng, Jingjing; Zhang, Ruijie; Pu, Liyuan; Qian, Suying; Xu, Shan; Jiang, Yannan; Pan, Lifang; Dai, Xiaoyu; Guo, Xu; Han, Liyuan.
Afiliação
  • Wang H; Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Zhao T; Center for Cardiovascular and Cerebrovascular Epidemiology and Translational Medicine, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China.
  • Zeng J; Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Zhang R; Center for Cardiovascular and Cerebrovascular Epidemiology and Translational Medicine, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China.
  • Pu L; Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Qian S; Center for Cardiovascular and Cerebrovascular Epidemiology and Translational Medicine, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China.
  • Xu S; Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Jiang Y; Center for Cardiovascular and Cerebrovascular Epidemiology and Translational Medicine, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China.
  • Pan L; Department of Clinical Epidemiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Dai X; Center for Cardiovascular and Cerebrovascular Epidemiology and Translational Medicine, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China.
  • Guo X; Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
  • Han L; Shen zhen Nanshan Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Proteomics Clin Appl ; : e2300233, 2024 May 10.
Article em En | MEDLINE | ID: mdl-38726756
ABSTRACT

PURPOSE:

This paper is to offer insights for designing research utilizing Olink technology to identify biomarkers and potential therapeutic targets for disease treatment. EXPERIMENTAL

DESIGN:

We discusses the application of Olink technology in oncology, cardiovascular, respiratory and immune-related diseases, and Outlines the advantages and limitations of Olink technology.

RESULTS:

Olink technology simplifies the search for therapeutic targets, advances proteomics research, reveals the pathogenesis of diseases, and ultimately helps patients develop precision treatments.

CONCLUSIONS:

Although proteomics technology has been rapidly developed in recent years, each method has its own disadvantages, so in the future research, more methods should be selected for combined application to verify each other.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Proteomics Clin Appl Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Proteomics Clin Appl Ano de publicação: 2024 Tipo de documento: Article